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and Its Relevance to TCRz/CD3 Induction
of Interleukin-2
Monika Raab,*† Antonio J. da Silva,*‡ Paul R. Findell,§ The proto-oncogene Vav was first identified by its
transforming activity in fibroblasts (Katzav et al., 1989).and Christopher E. Rudd*‡
*Division of Tumor Immunology Vav is specifically expressed in hematopoietic cells and
contains a number of structural motifs, including a puta-Dana-Farber Cancer Institute
†Department of Medicine tive guanine nucleotide exchange factor (Dbl) domain
for the Rho/Rac/CDC42 family of small GTPases; a‡Department of Pathology
Harvard Medical School Pleckstrin homology domain, which may participate in
membrane localization; a cysteine-rich domain, whichBoston, Massachusetts 02115
§Roche Biosciences may form zinc fingers; and two Src homology 3 (SH3)
domains and a SH2 domain at its C-terminus, whichPalo Alto, California 94304
are presumably involved in protein–protein interactions
(Koch et al., 1991). Although structurally related to otherSummary
guanine nucleotide exchange factor domains, the target
of the Dbl domain has yet to be established (Bustelo etT cell activation stimulates p56lck, p59fyn, ZAP-70, Vav–
al., 1994; Gulbins et al., 1993; Khosravi-Far et al., 1994).SLP-76 binding, and IL-2 transcription. Major ques-
Vav deficiency shows a role for the protein in efficienttions concern the tyrosine-kinase and relevant site(s)
development of T and B cells (Fischer et al., 1995; Tarak-needed for Vav–SLP-76 complex formation and its role
hovsky et al., 1995; Zhang et al., 1995). In this context,in IL-2 production. Here, we show that of the three
Vav is constitutively phosphorylated in thymocyteskinases, only ZAP-70 phosphorylates SLP-76 at spe-
(Gouy et al., 1995), while TCRz/CD3 or TCRz/CD3-CD4cific sites that allow Vav SH2 domain binding. There-
ligation induces its phosphorylation in peripheral T cellsfore, while p56lck regulates proximal events, ZAP-70
(Bustelo and Barbacid, 1992; Margolis et al., 1992). T cellacts downstream on targets such as SLP-76. We also
activation is defective in the absence of Vav expressionshow by in vitro and in vivo analysis that two SLP-76
(Tarakhovsky et al., 1995; Zhang et al., 1995). Further,pYESP motifs (Y113 and Y128) mediate binding, the
the overexpression of the protein has been reported tofirst being more efficient. A third pYEPP motif (Y145)
augment TCRz/CD3-induced interleukin-2 (IL-2) tran-failed to bind. Finally, TCRz/CD3 ligation of T cell hy-
scription (Motto et al., 1996; Wu et al., 1996). The SH2bridoma DC27.10 induces IL-2 production without de-
domain of Vav can bind to a YESP motif within ZAP-70tectable Vav–SLP-76 binding. Therefore, despite ef-
(Katzav et al., 1994). A number of proteins have beenfects of Vav–SLP-76 on IL-2 expression, Vav–SLP-76
reported to interact with Vav, including Grb-2, Shc, ZAP-binding per se is not essential for IL-2 production in
70, ITK, and SLP-76 (Katzav et al., 1994; Onodera et al.,all T cells.
1996; Wu et al., 1996; Ye and Baltimore, 1994).
Recently cloned SLP-76 has been reported as a po-Introduction
tential downstream link to Vav (Wu et al., 1996). The
protein contains potential tyrosine phosphorylation sitesLigation of the T cell receptor (TCRz/CD3) and the CD4/
in its N-terminus, a C-terminal SH2 domain, and a centralCD8-p56lck coreceptors activates Src protein-tyrosine
proline-rich region that interacts with SH3 domain-con-kinases p56lck and p59fyn (Rudd et al., 1994), which in turn
taining proteins such as Grb-2. As in the case of Vav,leads to phosphorylation of immunoreceptor tyrosine-
SLP-76 is specifically expressed in hematopoietic cellsbased activation motifs (ITAMs) within the TCRz and
and undergoes tyrosine phosphorylation upon TCRCD3 chains (Samelson and Klausner, 1992; Weiss and
cross-linking (Bubeck Wardenburg et al., 1996; MottoLittman, 1994; Mustelin, 1994; Wange and Samelson,
et al., 1996; Onodera et al., 1996; Wu et al., 1996). Con-1996). p56lck phosphorylation of TCR components re-
cordantly, receptor ligation induces the binding of Vavsults in the recruitment of ZAP-70 via tandem Src homol-
to SLP-76 via its SH2 domain (Onodera etal., 1996; Wu etogy 2 (SH2) domain binding (Wange et al., 1993; Iwa-
al., 1996). Further, overexpression of SLP-76 augmentsshima et al., 1994) and possibly other proteins such as
TCR/CD3-induced IL-2 promoter activityand may syner-Shc (Ravichandran et al., 1993). ZAP-70 catalytic activity
gize with Vav in augmenting IL-2 transcription (Wu etis then up-regulated by p56lck phosphorylation (Chan et
al., 1996). These SLP-76-mediated effects depend onal., 1995; Wange et al., 1995). The activation of Src family
the integrity of its SH2 domain (Motto et al., 1996), aand Syk/ZAP-70 protein-tyrosine kinases leads to phos-
domain that binds to two substrates at 62 kDa and 120phorylation of numerous cellular proteins, including CD5
kDa (Motto et al., 1996). Taken together, these observa-(Burgess et al., 1992; Raab et al., 1994), phospholipase
tions support an important role for the Vav–SLP-76 com-C-g1 (PLC-g1) (Weiss et al., 1991), the proto-oncogene
plex in IL-2 gene activation.Vav (Bustelo and Barbacid, 1992; Gulbins et al., 1993),
A key question concerns the identity of the tyrosinep120/130 (da Silva et al., 1993, 1997), c-cbl (Donovan
kinase and the sites that regulate Vav–SLP-76 bindinget al., 1994; Reedquist et al., 1996), and the recently
and whether the interaction itself, or another propertycloned SLP-76 (Jackman et al., 1995). While tyrosine
of these proteins, is required for TCR-mediated IL-2phosphorylation of PLC-g1 regulates its enzymatic ac-
production. In this report, we show that despite thetivity, leading to the activation of the inositol phospho-
lipid pathway, the significance of the tyrosine phosphor- presence of multiple kinases associated with TCR/CD3-
CD4, only the ZAP-70 tyrosine kinase regulates theylation of Vav and SLP-76 remains unclear.
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Figure 1. Phosphorylation of SLP-76 by the Protein-Tyrosine Kinase ZAP-70
(A) Differential phosphorylation of SLP-76 by the p56lck, p59fyn, and ZAP-70 kinases. SLP-76 was either expressed alone (lane 1) or in the
presence of Lck (lane 2), Fyn (lane 3), or ZAP-70 (lane 4) in Sf21 cells. Lysates were prepared in 1% Triton X-100 lysis buffer, immunoprecipitated
with anti-SLP-76 antibody (lanes 1–4), and immunoblotted with an anti-pTyr antibody.
(B) Differential phosphorylation of TCRz by the p56lck, p59fyn, and ZAP-70 kinases. z was either expressed alone (lane 1) or in the presence of
Lck (lane 2), Fyn (lane 3), or ZAP-70 (lane 4). Lysates were immunoprecipitated with anti-z antibody (lanes 1–4) and immunoblotted with an
anti-pTyr antibody. Lanes show cells expressing z (lane 1), Lck/z (lane 2), Fyn/z (lane 3), and ZAP-70/z (lane 4).
(C) Phosphorylation of Vav by the p56lck, p59fyn, and ZAP-70 kinases. Vav was either expressed alone (lane 1) or in the presence of Lck (lane
2), Fyn (lane 3), or ZAP-70 (lane 4). Lysates were immunoprecipitated with anti-Vav antibody (lanes 1–4) and immunoblotted with an anti-pTyr
antibody. Lanes show cells expressing Vav (lane 1), Lck/Vav (lane 2), Fyn/Vav (lane 3), and ZAP-70/Vav (lane 4). Equivalent levels of SLP-76,
z, or Vav were present in all lanes as demonstrated by immunoblotting with an anti-SLP-76 MAb, anti-z MAb, or anti-Vav MAb, respectively.
Densitometric analysis was carried out using the Scantjet laser scanner (Hewlett-Packard) of anti-pTyr binding to SLP-76 (A), z (B), or Vav (C)
(D) The absence of binding between SLP-76 and various kinases. Sf21 cells infected with virus carrying cDNA encoding SLP-76, Lck, Fyn,
ZAP-70, or combinations of them were lysed, immunoprecipitated with anti-SLP-76 (lane 1), anti-Lck (lane 2), anti-Fyn (lane 3), and anti-ZAP-
70 (lane 4) and immunoblotted with an anti-SLP-76 antibody. Positions of molecular mass markers (in kilodaltons) are indicated.
phosphorylation and interaction of SLP-76 with the Vav SLP-76 (Katzav et al., 1994; Onodera et al., 1996; Wu
et al., 1996). In transfection analysis, Vav and SLP-76SH2 domain. p56lck failed to phosphorylate SLP-76 sig-
nificantly, while p59fyn phosphorylated SLP-76 without cooperate to increase IL-2 transcription (Wu et al., 1996)
under circumstances in which the SH2 domain of Vavinducing an interaction with Vav. Further, we show by
various means that the two pYESP motifs of SLP-76 binds to SLP-76 (Onodera et al., 1996; Wu et al., 1996).
A key event in the control of this interaction involves amediate binding to the Vav SH2 domain, with the first
pYESP motif (residues 113–116) dominating. Finally, kinase that phosphorylates the appropriate site. Al-
though p56lck, p59fyn, and ZAP-70 associate with thewhile Vav and SLP-76 augment IL-2, we demonstrate
by using the T cell hybridoma DC27.10 that Vav–SLP- CD4/CD8 or TCR/CD3complexes, little is known regard-
ing their specificities for downstream elements of the76 binding is not required for IL-2 production in all T cells.
signaling pathway. To identify the kinase, we initially
coexpressed SLP-76 with p56lck, p59fyn, and ZAP-70 inResults
heterologous cells and assessed phosphorylation of the
protein (Figure 1A). While ZAP-70 caused appreciableRecent studies have defined a downstream cascade
from the TCRz/CD3 complex involving ZAP-70 and Vav– phosphorylation of SLP-76 (Figure 1A, lane 4), p56lck
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induced little SLP-76 phosphorylation (lane 2). p59fyn kinase responsible for the phosphorylation of Vav, a
protein that becomes tyrosine phosphorylated in T cellsphosphorylated SLP-76 at some 20%–30% of that ob-
served for ZAP-70 (lane 3). Specificity in this system as a consequence of TCR ligation (Bustelo and Bar-
bacid, 1992; Margolis et al., 1992). In this case, all threewas shown by the dramatic difference in the phosphory-
lation of TCRz relative to SLP-76 by the different kinases kinases, p56lck, p59fyn, and ZAP-70, phosphorylated the
substrate, although Fyn was consistently found to be(Figure 1B). Consistent with another report (Iwashima
et al., 1994), TCRz phosphorylation was mediated pri- the most efficient (Figure 1C, lane 3).
Given the apparent specificity of phosphorylation ofmarily by p56lck and to a lesser extent by p59fyn (Figure
1B, lanes 2 and 3, respectively). Further, no ZAP-70 SLP-76 by ZAP-70, it was of interest to assess whether
ZAP-70 could regulate binding between Vav and SLP-76phosphorylation of TCRz was observed (lane 4). As a
control for expression, SLP-76 and z expression were (Figure 2A). Vav and SLP-76 weretherefore coexpressed
with the kinase and assessed for binding. No SLP-76found to be equivalent in the presence of the different
kinases and, further, each kinase was expressed at simi- was present in anti-Vav precipitations in the presence
of Lck (Figure 2A, lane 1) or in the absence of kinaselar levels (Figure 1, middle panels). Kinase phosphoryla-
tion of SLP-76 occurred without any indication of physi- (data not shown). However, in the presence of ZAP-
70, anti-Vav precipitated significant levels of SLP-76, ascal binding between kinase and substrate (Figure 1D).
Precipitation of p56lck, p59fyn, or ZAP-70 failed to copre- detected by immunoblotting (Figure 2A, lane 3). As a
control, anti-Vav blotting of lysates showed that equiva-cipitate SLP-76 (Figure 1D, lane 1 versus lanes 2–4).
For the purpose of comparison, we also examined the lent amounts of Vav were expressed in the cells (Figure
Figure 2. ZAP-70 Regulates Binding between Vav and SLP-76
(A) Coexpression of ZAP-70 induces binding between Vav and SLP-
76. Sf21 cells were coinfected with Lck/Vav–SLP-76 (lanes 1 and 2)
or ZAP-70/Vav–SLP-76 (lanes 3 and 4), lysed, immunoprecipitated
with anti-Vav (lanes 1 and 3) orSLP-76 (lanes 2 and 4), and subjected
to immunoblotting with anti-SLP-76 antiserum. Equivalent levels of
Vav were expressed as demonstrated by immunoblotting of the cell
lysate with an anti-Vav MAb.
(B) ZAP-70 phosphorylation of SLP-76, but not Vav, induces com-
plex formation. Lysates from cells infected with virus carrying cDNAs
encoding SLP-76 (lanes 1 and 9), Lck/SLP-76 (lanes 2 and 10), Fyn/
SLP-76 (lanes 3 and 11), and ZAP-70/SLP-76 (lanes 4 and 12) were
combined with the lysate of Sf21 cells expressing Vav. Lysates of
cells expressing Vav (lanes 5 and 13), Lck/Vav (lanes 6 and 14), Fyn/
Vav (lanes 7 and 15), and ZAP-70/Vav (lanes 8 and 16) were combined with the lysate of cells expressing SLP-76. After mixing lysates,
immunoprecipitates using anti-Vav antibody (lanes 1–8) or anti-SLP-76 antibody (lanes 9–16) were prepared and subjected to immunoblotting
with anti-SLP-76 antiserum (lanes 1–8) or anti-Vav antiserum (lanes 9–16). Cells expressing SLP-76, Lck/SLP-76, Fyn/SLP-76, and ZAP-70/
SLP-76 were immunoprecipitated with anti-SLP-76 antibody and subjected to immunoblotting with anti-SLP-76 antiserum. Cells expressing
Vav, Lck/Vav, Fyn/Vav, and ZAP-70/Vav were immunoprecipitated with anti-Vav antibody and subjected to immunoblotting with anti-Vav
antiserum.
(C) Phosphatase digestion disrupts the Vav–SLP-76 complex. Sf21 cells coinfected with viruses carrying ZAP-70 and SLP-76 cDNAs (lanes
1–4) were lysed and treated with (lanes 2 and 4) or without (lanes 1 and 3) 50 U of alkaline phosphatase (Boehringer Mannheim) for 1 hr at
378C. After dephosphorylation, the lysates were combined with lysates of cells expressing Vav, followed by immunoprecipitation with anti-
Vav and immunoblotting with anti-pTyr antibody (lanes 1 and 2) or anti-SLP-76 antibody (lanes 3 and 4).
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Figure 3. Vav SH2 Domain Binds to the YESP Motifs within SLP-76
(A) Peptides corresponding to the two pYESP motifs precipitate Vav. A depiction is shown of the SLP-76 antigen: residues 101–154 comprise
peptide A (109–119) and peptide B (124–134), including the YESP motifs (113–116 and 128–131) and peptide C (142–151) with the YEPP motif
(145–148) (upper panel). Lysates from Sf21 cells infected with virus carrying cDNA encoding Vav were incubated with different amounts of
AminoLink Plus–coupled bovine serum albumin (BSA) (lanes 1 and 2), nonphosphorylated peptide A (lanes 3–5), phosphorylated peptide A
(lanes 6–8), nonphosphorylated peptide B (lanes 10–12), phosphorylated peptide B (lanes 13–15), combined phosphorylated peptides A and
B (lanes 16–18), phosphorylated peptide C (lanes 19–21), and an unrelated control phospho-peptide X with the sequence QKQFQPpYFIPIN
(lanes 22–24). The precipitates were subjected to immunoblotting with anti-Vav antiserum (lanes 1–24). Lane 9 shows as a positive control
immunoprecipitation with anti-Vav antibody (lower panel).
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2A, lower panel). To verify that ZAP-70 phosphorylation SLP-76, two YESP sites (residues 113–116 and 128–
131), and one YEPP site (residues 145–148) that resem-of SLP-76 was required for the association, lysates from
cells expressing SLP-76 and various kinases were mixed ble the YESP site within ZAP-70 (Y315) (Katzav et al.,
1994). To test which of these motifs bound to Vav, phos-with lysates expressing Vav alone and assessed for
binding. We previously established this system to dem- phorylated and nonphosphorylated peptides corre-
sponding to each site EEDDYESPNDD (peptide A),onstrate binding between other protein-bindingpartners
(Raab et al., 1995; Raab and Rudd, 1996). Under these DDGDYESPNEE (peptide B), and DDADYEPPPSN (pep-
tide C) were initially coupled to AminoLink Plus beadsconditions, ZAP-70 phosphorylation of sites in SLP-76
was clearly able to induce binding to Vav (Figure 2B). and used to precipitate Vav from cell lysates (Figure 3A).
Anti-Vav was then used in immunoblotting. Phosphory-Anti-Vav could precipitate SLP-76 (Figure 2B, lane 4),
and anti-SLP-76 could precipitate Vav (lane 12). By con- lated peptides A and B precipitated Vav in a manner
correlated with the amount of peptide (Figure 3A, lanestrast, neither Src kinase p56lck (which phosphorylated
little SLP-76; Figure 2B, lanes 2 and 10) nor p59fyn (which 6–8 and 13–15), and peptide C failed to precipitate de-
tectable protein (lanes 19–21). Increasing amounts ofphosphorylated the protein) could induce Vav–SLP-76
complex formation (lanes 3 and 11). Attempts to increase Vav were precipitated by 1 mg, 5 mg, and 10 mg of phos-
phorylated peptides A and B. Nonphosphorylated formsthe sensitivity of detection by increasing amountsof lysate
also failed to show complex formation using Src kinases of the peptides A and B precipitated little material (Fig-
ure 3A, lanes 3–5 and 10–12). Additional negative con-(data not shown). This difference among kinases demon-
strates the specificity of ZAP-70 in regulating the Vav– trols included bovine serum albumin (Figure 3A, lanes
1 and 2) and an unrelated control phosphopeptide XSLP-76 interaction. As a control, SLP-76 and Vav ex-
pression were monitored and found to be equivalent in (QKQFQPpYFIPIN; residues 212–223 of CTLA-4), which
precipitate little antigen (lanes 22–24). Peptide A wasthe presence of different kinases as detected by immu-
noblotting (Figure 2B, lower panel). The same result was routinely found to serve as a more efficient matrix for
Vav binding. For example, at 1 mg, peptide A precipitatedobserved in multiple experiments.
Although the above data showed that ZAP-70 phos- some 5- to 6-fold more Vav than did peptide B (Figure
3A). Combinations of peptide A and peptide B (0.5 mgphorylation was sufficient to facilitate complex forma-
tion, we also tested whether the interaction occurred plus 0.5 mg) also precipitated Vav (lanes 16–18), but
generally at the same or slightly lower efficiency thanonly in one direction. Despite the fact that Vav can also
be phosphorylated by the various kinases (Figure 1C), peptide A alone. There is therefore noevidence for coop-
erativity when the twopeptides areused together. Theseits phosphorylation by Lck (Figure 2B, lanes 6 and 14),
Fyn (lanes 7 and 15), and ZAP-70 (lanes 8 and 16) failed data show that the two SLP-76 pYESP motifs, but not
the YEPP site, can bind to the Vav SH2 domain.to allow for binding to SLP-76, a result consistent with
previous reports (Onodera et al., 1996; Wu et al., 1996). We next showed that phosphorylated peptides A and
B could successfully dissociate Vav–SLP-76 complexIn an effort to verify that the binding was dependent
on tyrosine phosphorylation, we assessed Vav–SLP-76 that had been induced by ZAP-70 (Figure 3B). A similar
approach has been used previously to identify sites ofcomplexes for an ability to remain associated in the
presence of alkaline phosphatase (Figure 2C). Under this SH2 binding (Fantl et al., 1992; Roussel et al., 1991).
Dissociation of SLP-76 from anti-Vav precipitates (Fig-regime, alkaline phosphatase both dephosphorylated
SLP-76 (Figure 2C, lane 2 versus 1) and disrupted bind- ure 3B, lanes 6–11) occurred in a concentration-depen-
dent manner over a range of 10–100 mM (lanes 6–11).ing to Vav (lane 4 versus 3).
Although others have shown that the Vav SH2 domain Nonphosphorylated peptides failed to compete for bind-
ing (lanes 1–5). Equivalent levels of Vav protein wererecognizes phospho-SLP-76 (Onodera et al., 1996; Wu
et al., 1996), the sites of recognition are not known. To present in all immunoprecipitates as detected by immu-
noblotting (Figure 3B, middle panel). In this regime, pep-define the region within SLP-76 that is phosphorylated
by ZAP-70 and which mediates binding to Vav, we fur- tide A was again found to be more efficient (2- to 3-fold
more effective) in competing than the peptide corre-ther investigated the Vav SH2-binding sites within SLP-
76. Of particular interest are three possible sites within sponding to the second pYESP motif (peptide B) (Figure
(B) Peptides corresponding to the two pYESP motifs compete for Vav–SLP-76 binding. Lysates from cells infected with viruses containing
cDNAs encoding ZAP-70 and SLP-76 were combined with lysate from cells expressing Vav and incubated without (lane 1) or with different
concentrations of nonphosphorylated peptide A (lanes 2 and 3), nonphosphorylated peptide B (lanes 4 and 5), phosphorylated peptide A
(lanes 6–8), and phosphorylated peptide B (lanes 9–11). After immunoprecipitation with anti-Vav antibody, the precipitates were subjected to
immunoblotting with anti-SLP-76 antiserum. Equivalent levels of Vav were present in all lanes as demonstrated by immunoblotting with an
anti-Vav antibody (middle panel). Densitometric analysis of the competition experiment (lower panel).
(C) Mutation of pYESP/YEPP sites abrogates ZAP-70 phosphorylation and Vav binding. Sf21 cells were coinfected with ZAP-70 and SLP-76
(lanes 1 and 3) or ZAP-70 and SLP-76-FFF (lanes 2 and 4), lysed, immunoprecipitated with anti-SLP-76 (lanes 1 and 2) or combined with the
lysate of Sf21 cells expressing Vav and immunoprecipitated with anti-Vav (lanes 3 and 4), and subjected to immunoblotting with anti-SLP-76
antiserum (lanes 1 and 2, lower panel; lanes 3 and 4, upper panel) or anti-Tyr (lanes 1 and 2, upper panel).
(D) (Top panel) Peptides corresponding to the first pYESP motifs can compete for Vav SH2 domain binding to SLP-76. Sf21 cells were infected
with SLP-76 (lanes 1–3), coinfected with Lck/SLP-76 (lanes 4–6), Fyn/SLP-76 (lanes 7–9), or ZAP-70/SLP-76 (lanes 10–13), lysed in 1% Triton
X-100, and subjected to precipitation with GST alone (lane 10), GST–Lck SH2 (lanes 1, 4, 7, and 11), GST–Fyn SH2 (lanes 2, 5, 8, and 12), or
GST–Vav SH2/SH3 (lanes 3, 6, 9, and 13). The precipitates were separated on an SDS–polyacrylamide gel (10%) and subjected to anti-SLP-
76 blotting. (Middle panel) ZAP-70/SLP-76-expressing Sf21 cells were lysed, incubated without (lane 1) or with different concentrations of
nonphosphorylated peptide A (lanes 2–4) and phosphorylated peptide A (lanes 5–7), and subjected to precipitation with GST–Vav SH2/SH3
and immunoblotting with anti-SLP-76 antibody. (Lower panel) Densitometric profile of SLP-76 in GST–Vav SH3/SH3 precipitates.
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3B, lower panel). Peptide concentrations as low as 10 were conducted, each of which showed the same re-
mM reduced binding by greater than 90% (Figure 3B, sults. Earlier timepoints were also examined from as
lane 6; see histogram). At the same concentration, pep- early as 20 s to 5 min (Figure 4B). Pervanadate activation
tide B reduced binding by 40%–50% The concentration also failed to induce an association as detected in anti-
of peptides used to compete for binding is comparable Vav (Figure 4D, lane 6) or anti-SLP-76 precipitates (lane
with those used to block other SH2-mediated interac- 9). Both anti-pTyr and anti-SLP-76 were used in an at-
tions, such as p85 SH2 binding to PDGF-R or CD28 tempt to detect the interaction (Figure 4D, upper and
(Fantl et al., 1992; Prasad et al., 1994). lower panels, respectively). As an important control, and
Confirmation of Vav binding to the YESP motifs was as described by others (Onodera et al., 1996; Wu et al.,
observed in vivo using SLP-76 with mutations at the 1996), the same experiments carried out using Jurkat
three sites (SLP-76-FFF) (Figure 3C). While coexpres- cells showed the coprecipitation of SLP-76 with anti-Vav
sion of wild-type SLP-76 and ZAP-70 resulted in SLP- as detected by anti-SLP-76 blotting (Figure 4E, lanes 3
76 phosphorylation (lane 1), mutation of the three sites and 4). These observations make the important point
almost completely eliminated phosphorylation (lane 2). that the Vav SH2 domain binding to SLP-76 per se is
Equivalent amounts of wild-type and mutant SLP-76 not required for TCR/CD3-induced IL-2 production in
protein were expressed (Figure 3C, lower panel). Elimi- all T cells and suggests that the basis for Vav–SLP-76
nation of these sites also prevented binding of Vav with cooperativity may be due toanother biochemical feature
SLP-76 in a mixed lysate experiment (Figure 3C, lane 4 of the SLP-76 and Vav signaling proteins.
versus 3). Given that the pYEPP site fails to bind to Vav
(Figure 3A), these data demonstrate that ZAP-70 in vivo
phosphorylation of one or both pYESP sites induces Discussion
Vav–SLP-76 binding.
To confirm in our system that the SH2 domain of Previous studies have shown that both Vav and SLP-
Vav mediates binding to SLP-76, we used glutathione 76 undergo tyrosine phosphorylation in response to TCR
S-transferase (GST) fusion proteins with the SH2/SH3 ligation, interact with each other, and augment NF-AT
domains of Vav in precipitation assays. The Vav SH2/ activity within the IL-2 promoter (Motto et al., 1996;
SH3 proteins specifically precipitated SLP-76 only when Onodera et al., 1996; Wu et al., 1996). Each of these
ZAP-70 was coexpressed with SLP-76 (Figure 3D, lane proteins may therefore participate in a signaling cas-
13). Specificity was shown by the fact that other GST cade initiated by ligation of the TCRz/CD3 and CD4–
constructs such as GST (Figure 3D, lane 10), GST–Lck p56lck complexes. A key question has concerned the
SH2 (lane 11), or GST–Fyn SH2 (lane 12) failed to precipi- identity of the kinase that regulates the interaction, and
tate the antigen. Since we used a construct that carried whether the interaction per se is required for TCRz/CD3
both the SH2 and SH3 domains, it was important to induction of IL-2 production. Although p56lck, p59fyn, and
confirm that the phosphotyrosine motif was responsible ZAP-70 associate with CD4/CD8 and TCRz/CD3 (Rudd
for binding to the SH2 domain. We therefore examined et al., 1994; Samelson and Klausner, 1992; Weiss and
the role of the SLP-76 pYESP motifs in Vav SH2 binding Littman, 1994), remarkably little is known regarding their
to ZAP-70-phosphorylated SLP-76. Under these condi-
general substrate specificities and regulation of down-
tions, we used phosphorylated peptide A and found it
stream signaling. p56lck and p59fyn can phosphorylate
(50–100 mM) to compete effectively for SH2 Vav binding
surface receptors such as TCRz, CD5, and CD28, each
to SLP-76 (Figure 3D, lower panel). These data indicate
of which possesses different tyrosine-based motifsthat the ZAP-70 kinase phosphorylated the pYESP site
(Iwashima et al., 1994; Burgess et al., 1992; Raab et al.,that is needed for Vav SH2 recognition.
1994, 1995). In terms of downstream targets, the abilityThe cooperativity of Vav–SLP-76 in augmenting IL-2
of Vav and SLP-76 to augment IL-2 and undergo com-transcription suggested that the interaction might be
plex formation provides an excellent model for examin-needed in IL-2 gene activation (Wu et al., 1996). To test
ing the downstream target specificities of TCR- andthis possibility, we investigated the interaction in a mu-
CD4/CD8-associated kinases. Here, we show that of therine T cell hybridoma (DC27.10) that produces high lev-
three kinases, only ZAP-70 was capable of phosphory-els of IL-2 in response to antigen receptor ligation (Yun-
lating SLP-76 in a manner that induced Vav–SLP-76Cai et al., 1995; Zamoyska et al., 1989). The T cells
binding (Figure 2). Specificity in our expression systemexpressed high levels of CD3 and showed a normal
was shown by the mirror image pattern produced byarray of TCRz and CD3 subunits as assessed by two-
p56lck and ZAP-70 in the phosphorylation of SLP-76 rela-dimensional isoelectric focusing (data not shown). Sig-
tive to TCRz (Figure 1). While SLP-76 was readily phos-nificantly, although these cells produced high amounts
phorylated by ZAP-70, little phosphorylation was ob-of IL-2, with maximal levels of IL-2 observed at 1029 M
served by Lck. Conversely, TCRz was phosphorylated(Figure 4C), no binding between SLP-76 and Vav was
by p56lck, with no observable phosphorylation by ZAP-detected as a consequence of TCR/CD3 ligation. Activa-
70 (Figure 1), a result that is consistent with a previoustion over varying lengths of time showed an increase in
report (Iwashima et al., 1994). Similar results were ob-phosphorylation of Vav (Figure 4A, lanes 7–9) and SLP-
tained with different levels of kinase expression (data76 (lanes 10–12) as detected by anti-phosphotyrosine
not shown). By contrast, p59fyn phosphorylated SLP-76(anti-pTyr) blotting. Under these conditions, no SLP-76
at intermediate levels but, significantly, this phosphory-could be found in anti-Vav precipitations (Figure 4A,
lation failed to induce Vav–SLP-76 complex formationlanes 7–9) as detected by anti-pTyr blotting (upper
(Figures 1 and 2). This suggests that the kinase phos-panel) or immunoblotting using SLP-76 antiserum (mid-
phorylates sites distinct from the pYESP sites and pointsdle panel). Conversely, no Vav was present in anti-SLP-
76 precipitations (lanes 10–12). At least six experiments to the distinct nature of this Src kinase relative to p56lck.
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Figure 4. Production of High Levels of IL-2 in the Absence of Detectable Vav–SLP-76 Complex Formation
(A) No binding between SLP-76 and Vav after TCR/CD3 ligation. Precipitations from lysates of DC27.10 exposed to anti-CD3 (2C11) and rabbit
anti-hamster (RaH) antibodies were subjected to immunoblotting with anti-pTyr antibody. Cells were cross-linked with anti-CD3 for 0 min
(lanes 1, 4, 7, and 10), 10 min (lanes 2, 5, 8, and 11), and 30 min (lanes 3, 6, 9, and 12). Cell lysates (lanes 1–3) or precipitations with preimmune
sera (lanes 4–6), anti-Vav antibody (lanes 7–9), or anti-SLP-76 antibody (lanes 10–12) are shown. Expression and precipitation of SLP-76 are
demonstrated by immunoblotting with an anti-SLP-76 antibody.
(B) Anti-Vav and anti-SLP-76 precipitations from lysates of DC27.10 exposed to anti-CD3 antibody (2C11) and rabbit anti-hamster (RaH)
antibody were subjected to immunoblotting with anti-Vav or anti SLP-76, respectively. Cells were cross-linked with anti-CD3 for 0 min (lanes
1 and 5), 20 s (lanes 2 and 6), 1 min (lanes 3 and 7), and 5 min (lanes 4 and 8).
(C) DC27.10 cells produce high levels of IL-2 after activation. IL-2 production in DC27.10 cells was analyzed by incubation with 2C11 at a
concentration of 10211 M to 1029 M for 24 hr. Supernatants were harvested and analyzed for IL-2 in triplicates.
(D) No binding between SLP-76 and Vav after pervanadate activation. Precipitations from lysates of DC27.10 exposed to anti-CD3 (2C11) and
rabbit anti-hamster (RaH) antibodies or pervanadate for 5 min at 378C were subjected to immunoblotting with anti-pTyr antibody. Shown are
unstimulated cells (lanes 1, 4, and 7) and cells stimulated with 2C11/RaH (lanes 2, 5, and 8) or pervanadate (lanes 3, 6, and 9). Cell lysates
(lanes 1–3) or precipitations with anti-Vav antibody (lanes 4–6) or anti-SLP-76 antibody (lanes 7–9) are shown. Expression and precipitation
of SLP-76 are demonstrated by immunoblotting with an anti-SLP-76 antibody.
(E) Binding between SLP-76 and Vav in Jurkat cells. Precipitations from lysates of Jurkat cells exposed to anti-CD3 antibody (OKT3) and
rabbit anti-mouse (RaM) antibody for 5 min at 378C were subjected to immunoblotting with anti-pTyr antibody (lanes 1 and 2) and anti-SLP-
76 antibody (lanes 3 and 4). Precipitations with anti-Vav antibody (lanes 1 and 3) and anti-SLP-76 antibody (lanes 2 and 4) are shown.
Taken together, these data are consistent with a sce- binds to SLP-76; however, neither the kinase responsi-
ble nor the sites of binding were known. Here, we shownario in which p56lck regulates proximal events such as
ZAP-70 recruitment, while ZAP-70 acts further down- that phosphorylated versions of peptides corresponding
to both pYESP sites (residues 113–116 and 128–131)stream on targets such as SLP-76.
Previous work has shown that the SH2 domain of Vav could successfully precipitate Vav and could compete
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for the binding of Vav induced by ZAP-70 phosphoryla- transfection and overexpression of protein beyond en-
dogenous levels. From this analysis one must concludetion of SLP-76. A similar Vav SH2-binding motif (residues
315–318) with the pYESP sequence also resides within that Vav SH2 domain binding to SLP-76 is not strictly
required for the ability of the TCRz/CD3 complex toZAP-70 (Katzav et al., 1994). By contrast, a third putative
binding motif pYEPP (residues 145–148) failed to bind induce IL-2 production in all T cells.
Our findings may also provide an explanation for theto Vav. Vav therefore exhibits specific binding to the
pYESP motif, where a substitution of the serine residue apparent discordance between the levels of Vav–SLP-
76 binding and IL-2 production in Jurkatcells expressingwith proline in the 13 position disrupts binding. Coex-
pression studies using the SLP-76 triple mutant con- different isoforms of CD45 (McKenney et al., 1995;
Onoderaet al.,1996). It is important tonote that althoughfirmed that YESP sites are the principle in vivo sites for
ZAP-70 phosphorylation (Figure 3C). Since the pYEPP Vav–SLP-76 binding is not required for TCR-mediated
IL-2 production, it could still amplify the response in Tsite cannot bind to Vav (Figure 3A), one or both pYESP
sites mediates in vivo binding to Vav (Figure 3C). The cells. Cooperativity between Vav and SLP-76 could also
be related to their independent actions in downstreampYESP motifs are therefore possibly conserved in T cells
as an general docking site for Vav. It is also noteworthy signaling. For example, independent signals may con-
verge downstream in the regulation of a common target.that the two pYESP sites of SLP-76 are not equal in
mediating binding. The first pYESP motif was three to In this context, the SLP-76 SH2 domain binds indepen-
dently to two substrates at 62 kDa and 120 kDa (Motto etfive times more efficient than the second motif in either
precipitating Vav or competing for Vav–SLP-76 binding, al., 1996). We are presently examining the downstream
signaling pathways of Vav and SLP-76 in TCR/CD3-suggesting that this motif will dominate in binding. Con-
sistent with our findings, a recent report found that ZAP- mediated T cell activation.
70 could phosphorylate the YESP peptides in in vitro
assays (Bubeck Wardenburg et al., 1996). Coexpression Experimental Procedures
of truncated catalytic forms of p56lck with ZAP-70 was
Cells and Antibodiesneeded for significant SLP-76 phosphorylation, al-
The Spodoptera frugiperda (Sf) cell line IPLB-SF21 was obtainedthough an effect of phosphorylation on SLP-76 and Vav
from Invitrogen and was propagated as a monolayer culture in Sf 900
binding was not examined. In oursystem, ZAP-70 kinase insect medium (GIBCO BRL) supplemented with 10% fetal bovine
alone sufficed to phosphorylate the sites needed for Vav serum and 50 mg/ml gentamycin according to the procedure of
SH2 binding to SLP-76, thus distinguishing its action Brown and Faulkner (1977). Viral infections were performed at a
multiplicity of infection of 5 for protein production or of 0.1 for virusfrom a potential back-regulatory effect of ZAP-70 on
production. The murine T cell hybridoma, DC27.10 (gift of Dr. R.Lck. Taken together, these data demonstrate that ZAP-
Zamoyska, Medical Research Council, London), or Jurkat cells were70 phosphorylates one or both pYESP motifs within
cultured in RPMI 1640 medium supplemented with 5% (v/v) fetal
SLP-76, which bind to the Vav SH2 domain. The conse- bovine serum and 1% (w/v) penicillin–streptomycin at 378C in an
quences of SH2 binding are not known, although it could atmosphere containing 5% CO2. Monoclonal antibodies (MAbs) to
regulate Dbl activity in manner analogous to the effect of human Vav were provided by Dr. J. D. Griffin (Dana-Farber Cancer
Institute, Boston, MA). Rabbit antisera against p59fyn(T) and p56lckSH2 domain binding on SH-PTP2 phosphatase activity
were generated against synthetic peptides corresponding to resi-(Pluskey et al., 1995).
dues 35–51 and 39–64, respectively. Antisera against ZAP-70 werePrevious studies have shown that, although they are
provided by Dr. T. Mustelin (La Jolla Institute for Allergy and Immu-
structurally unrelated, in transfection analysis Vav and nology, La Jolla, CA). MAbs to SLP-76 were provided by Dr. P. R.
SLP-76 cooperate in augmenting TCR-mediated IL-2 Findell (Institute of Biochemistry and Cell Biology, Palo Alto, CA).
transcription (Motto et al., 1996; Wuet al., 1996). This has Anti-pTyr MAb 4G10 was provided by Dr. T. Roberts (Dana-Farber
Cancer Institute). Rabbit anti–mouse immunoglobulin was obtainedlead to the interpretation that the physical interaction of
from Dako Corporation (Carinteria, CA) and anti-murine CD3 (2C11)Vav and SLP-76 regulates IL-2 production in a cascade
was from American Type Culture Collection.from the TCRz/CD3 complex. One complication in this
model is the observation that the Vav SH2 domain binds
Baculovirus Expression Systemto pYESP sites in both ZAP-70 and SLP-76. Hence, in cDNAs encoding full-length p59fyn(T), p56lck, ZAP-70, Vav, SLP-76,and
this scheme, a cascade could involve sequential binding the triple mutant of SLP-76 YYY/FFF (provided by Dr. R. Perlmutter,
and dissociation of Vav from ZAP-70 to SLP-76. Alterna- Seattle, WA; Dr. G. Raab, Boston, MA; Dr. B. Seed, Boston, MA;
Dr. J. D. Griffin, Boston, MA; and Dr. P. R. Findell, Palo Alto, CA,tively, ZAP-70 and SLP-76 could compete with each
respectively)were either amplified by PCRwith specificoligonucleo-other for Vav binding. To test the requirement for Vav–
tides that included restriction sites for subcloning into the transferSLP-76 binding, we identified a T cell hybridoma
vector pVL1392 or pVL1393 or directely cloned. S. frugiperda (Sf21)(DC27.10) that produces high levels of IL-2 in the ab-
cells were then transfected with a mixture of linear wild-type bacu-
sence of detectable Vav–SLP-76 complex formation loviral DNA (Invitrogen, San Diego, CA) and the pVL1392/pVL1393-
(Figure 4). No binding was observed despite anti-CD3 DNA constructs and screened for recombinant virus plaques. Re-
induction of Vav and SLP-76 phosphorylation. Examina- combinant virus was purified from contaminating wild-type virus by
two rounds of plaque purification.tion of both early and later times following receptor
cross-linking failed to show binding. Additional attempts
Immunoprecipitation and Immunoblottingto facilitate binding by means of pervanadate activation
Cells (1.5 3 106) were infected with the baculovirus encoding thealso failed to show binding (Figure 4D). At the same
different proteins. After 2 days, cells were harvested and lysed with
time, we could consistently show Vav–SLP-76 binding in 200 ml of lysis buffer (20 mM Tris–HCl [pH 8.0], 150 mM NaCl, 1%
Jurkat cells (Figure 4E). Our system offers the advantage [v/v] Triton X-100, 1 mM sodium vanadate, 1 mM PMSF, 1 mM
that the role of the Vav–SLP-76 interaction could be leupeptin). Immunoprecipitation was carried out by incubation of
the lysate with the antibody for 1 hr at 48C, followed by incubationexamined in a T cell hybridoma without the need for
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with 50 ml of protein A–Sepharose beads (10% [w/v]) for 1 hr at 48C. Bustelo, X., and Barbacid, M. (1992). Tyrosine phosphorylation of
the vav proto-oncogene product in activated B cells. Science 256,Immunoprecipitates were washed three times with ice-cold lysis
buffer and subjected to SDS–PAGE. For immunoblotting, the immu- 1196–1199.
noprecipitates from 1 3 106 to 2 3 106 cells were separated by Bustelo, X.R., Suen, K.L., Leftheris, K., Meyers, C.A., and Barbacid,
SDS–PAGE and transferred onto nitrocellulose filters (Schleicher M. (1994). Vav cooperates with Ras to transform rodent fibroblasts
and Schuell, Keene, NH). Filters were blocked with 5% (w/v) skim- but is not a Ras GDP/GTP exchange factor. Oncogene 9, 2405–2413.
milk for 1 hr in Tris-buffered saline (pH 8.0) and then probed with the Chan, A.C., Dalton, M., Johnson, R., Kong, G.H., Wang, T., Thoma,
indicated antibody. Bound antibody was revealed with horseradish R., and Kurosaki, T. (1995). Activation of ZAP-70 kinase activity by
peroxidase–conjugated rabbit anti-mouse or donkey anti-rabbit an- phosphorylation of tyrosine 493 is required for lymphocyte antigen
tibodies using enhanced chemiluminescence (ECL; Amersham). receptor function. EMBO J. 14, 2499–2508.
da Silva, A.J., Janssen, O., and Rudd, C.E. (1993). TcRz/CD3-p59fyn(T)Peptide Competition and Binding Analysis
associated p120/130 binds to the SH2 domain of p59fyn(T). J. Exp.Peptides were synthesized and HPLC purified by the Molecular
Med. 178, 2107–2113.Biology Core Facility (Dana-Farber Cancer Institute). The sequences
da Silva, A.J., Rosenfield, J.M., Mueller, I., Bouton, A., Hirai, H., andof the peptides used were as follows (with pY indicating the phos-
Rudd, C.E. (1997). Biochemical analysis of p120/p130: a protein-phorylated residue): phosphorylated peptide A, EEDDpYESPNDD;
tyrosine kinase substrate restricted to T and myeloid cells. J. Immu-unphosphorylated peptide A, EEDDYESPNDD; phosphorylated
nol. 158, 2007–2016.peptide B, DDGDpYESPNEE; unphosphorylated peptide B, DDGDY
Donovan, J.A., Wange, R.L., Langdon, W.Y., and Samelson, L.E.ESPNEE; phosphorylated peptide c, DDADpYEPPPSN; phosphory-
(1994). The protein product of the c-cbl protooncogene is the 120-lated peptide X, QKQFQPpYFIPIN (residues 212–223 of CTLA-4).
kDa tyrosine-phosphorylated protein in Jurkat cells activated viaFor the competition analysis, peptides were added to mixed cell
the T cell antigen receptor. J. Biol. Chem. 269, 22921–22924.lysates and incubated for 2 hr at 48C prior to immunoprecipitation
and immunoblotting. For the binding analysis, peptides were cou- Fantl, W.J., Escobeddo, J.A., Martin, G.A., Turck, M., Del Rosario,
pled to AminoLink Plus gel beads (Pierce, Rockford, IL). The beads F., McCormick, F., and Williams, L.T. (1992). Distinct phosphotyro-
were added to the lysate and incubated for 2 hr at 48C. The precipi- sines on a growth factor receptor bind to specific molecules that
tates were then washed three times with ice-cold lysis buffer and mediate different signaling pathways. Cell 69, 413–423.
subjected to SDS–PAGE and immunoblotting. Fischer, K.-D., Zmuldzinas, A., Gardner, S., Barbacid, M., Berstein,
A., and Guidos, C. (1995). Defective T-cell receptor signaling and
TCR/CD3-Mediated Activation of T Cells positive selection of vav-deficient CD41CD81 thymocytes. Nature
To activate Jurkat and the DC27.10 murine T cell hybridoma, 50 3 374, 474–477.
106 cells were either treated with pervanadate for 5 min at 378C or
Gillis, S., Frem, M.M., Ou, W., and Smith, K.A. (1978). T cell growthincubated with prewarmed RPMI media supplementedwith 2% FCS,
factor: parameters of production and a quantitative microassay forcontaining 5 mg/ml of 145-2C11 (anti-CD3e) or anti-hCD3 (OKT3)
activity. J. Immunol. 120, 2027–2032.and 10 mg/ml of the rabbit anti-mouse antibody at 378C for varying
Gouy, H., Debre, P., and Bismuth, G. (1995). The proto-oncogene Vavlengths of time. Following activation, cells were then rapidly pelleted
product is constitutively tyrosine-phosphorylated in normal humanand solubilized in lysis buffer as described above.
immature T cells. J. Immunol. 25, 3030–3034.
Gulbins, E., Coggeshall, K.M., Baier, G., Katzav, S., Burn, P., andIL-2 Assay
Altman, A. (1993). Tyrosine kinase-stimulated guanine nucleotideThe supernatants derived from cell cultures were stored at 2708C
exchange activity of vav in T cell activation. Science 260, 822–825.and thawed before IL-2 assay. CTLL-2 cells were grown in the pres-
ence of recombinant human IL-2. They were washed three times Iwashima, M., Irving, B.A., van Oers, N.S.C., Chan, A.C., and Weiss,
and plated at 2500 cells per well in a 96-well plate. A series of A. (1994). Sequential interactions of the TCR with two distinct cyto-
2-fold diluted supernatants were added to CTLL-2 cells. Cells were plasmic tyrosine kinases. Science 263, 1136–1139.
cultured for 24 hr followed by 18 hr of pulsing with 1 mCi of [3H]thymi- Jackman, J.K., Motto, D.G., Sun, Q., Tanemoto, M., Turck, C.W.,
dine before harvesting and counting. The amount of IL-2 in these Peltz, G.A., Koretzky, G.A., and Findell, P.R. (1995). Molecular clon-
supernatants was determined by comparison with the standard ing of SLP-76, a 76-kDa tyrosine phosphoprotein associated with
curve established with recombinant IL-2. The half-maximum of stim- Grb2 in T cells. J. Biol. Chem. 270, 7029–7032.
ulation is defined as 100 U/ml, as described previously (Gillis et al.,
Katzav, S., Martin-Zanca, D., and Barbacid, M. (1989). Vav, a novel
1978).
human oncogene derived from a locus ubiquitously expressed in
hematopoietic cells. EMBO J. 8, 2283–2290.
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